Nektar Therapeutics
Nektar Therapeutics scores highest on Torque (52) and lowest on Nitro (27). Its PosiPenta is 36.68 out of 100, weaker than most similar companies.
On the Penta Grid this week, Nektar Therapeutics is Grid #634 of 837 in the Healthcare sector in United States, and Grid #3,173 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Nektar Therapeutics | 36.68 | 35 | 29 | 27 | 52 | 41 |
| U.S. Physical Therapy, Inc. | 64.09 | 23 | 88 | 91 | 56 | 63 |
| Taysha Gene Therapies, Inc. | 40.74 | 21 | 41 | 37 | 48 | 56 |
| Damora Therapeutics, Inc. | 44.93 | 27 | 35 | 55 | 56 | 52 |
| InnovAge Holding Corp. | 61.51 | 13 | 87 | 74 | 56 | 77 |
| Rapport Therapeutics, Inc. | 38.71 | 21 | 17 | 45 | 61 | 50 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.89 |
| P/B ratio | 1.35 |
EEarnings
| Trailing EPS | ₹-1795.80 |
| Forward EPS | ₹-975.59 |
NNitro
| Price | 3388.90 |
| 52-week high | 10323.93 |
| 52-week low | 3163.48 |
| Fall from 52-week high | 67.2% |
TTorque
| Return on equity (ROE) | -35.76% |
| Debt-to-equity | 0.15 |
AAnchor
| Beta (price swings) | 1.27 |
| Market cap | ₹11,570 Cr |
| Insider holding | 0.38% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nektar Therapeutics' PosiPenta score?
Nektar Therapeutics' PosiPenta is 36.68 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Nektar Therapeutics stand on the Penta Grid?
On the Penta Grid this week, Nektar Therapeutics is Grid #634 of 837 in the Healthcare sector in United States, and Grid #3,173 of 4,000 in United States.
Which PosiPenta pillar is strongest for Nektar Therapeutics?
Torque (durability), with a score of 52 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Nektar Therapeutics?
Nitro (momentum), with a score of 27 out of 100: weaker than most similar companies.
Has Nektar Therapeutics' PosiPenta changed since last week?
Yes, it rose 2.59 points, from 34.09 to 36.68.
PositoAI is for research and education only and is not investment advice.